
WHO 'strongly advises against' use of antibody therapies as COVID treatment
Fox News
The World Health Organization (WHO) has flipped its position on antibody therapies to treat COVID as they believe the Omicron variant's latest offshoots have rendered them obsolete.
The virus has since evolved, and mounting evidence from lab tests suggests the two therapies - sotrovimab as well as casirivimab-imdevimab - have limited clinical activity against the latest iterations of the virus. As a result, they have also fallen out of favor with the U.S. health regulator.
More Related News